Cargando…

Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma

BACKGROUND: To retrospectively access outcome and toxicity of whole brain radiotherapy (WBRT) in patients with multiple brain metastases (BM) from malignant melanoma (MM). PATIENTS AND METHODS: Results of 87 patients (median age 58 years; 35 female, 52 male) treated by WBRT for BM of MM between 2000...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hauswald, Henrik, Dittmar, Jan-Oliver, Habermehl, Daniel, Rieken, Stefan, Sterzing, Florian, Debus, Jürgen, Combs, Stephanie E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444385/ https://www.ncbi.nlm.nih.gov/pubmed/22857154 http://dx.doi.org/10.1186/1748-717X-7-130

Ejemplares similares

Whole brain helical Tomotherapy with integrated boost for brain metastases in patients with malignant melanoma–a randomized trial
por: Hauswald, Henrik, et al.
Publicado: (2013)

Whole-brain helical tomotherapy with integrated boost for brain metastases in patients with malignant melanoma – final results of the BRAIN-RT trial
por: Hauswald, Henrik, et al.
Publicado: (2019)

Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma
por: Hauswald, Henrik, et al.
Publicado: (2015)

Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts
por: Rieken, Stefan, et al.
Publicado: (2012)

Intensity‐modulated radiotherapy versus proton radiotherapy versus carbon ion radiotherapy for spinal bone metastases: a treatment planning study
por: Rief, Harald, et al.
Publicado: (2015)

Stability of spinal bone metastases in breast cancer after radiotherapy: A retrospective analysis of 157 cases
por: Schlampp, Ingmar, et al.
Publicado: (2014)

Long term toxicity and prognostic factors of radiation therapy for secreting and non-secreting pituitary adenomas
por: Rieken, Stefan, et al.
Publicado: (2013)

Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas
por: Kosaki, Katsura, et al.
Publicado: (2012)

Re-irradiation in the treatment of patients with cerebral metastases of solid tumors: retrospective analysis
por: Scharp, Maike, et al.
Publicado: (2014)

Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
por: Harrabi, Semi B, et al.
Publicado: (2014)

High-dose single-fraction IMRT versus fractionated external beam radiotherapy for patients with spinal bone metastases: study protocol for a randomized controlled trial
por: Rief, Harald, et al.
Publicado: (2015)

Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma
por: El Shafie, Rami A., et al.
Publicado: (2018)

In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells
por: Combs, Stephanie E, et al.
Publicado: (2012)

Targeting α(ν)β(3 )and α(ν)β(5 )inhibits photon-induced hypermigration of malignant glioma cells
por: Rieken, Stefan, et al.
Publicado: (2011)

Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy
por: Habermehl, Daniel, et al.
Publicado: (2013)

Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients
por: Sterzing, Florian, et al.
Publicado: (2015)

Palliative radiation therapy in patients with metastasized pancreatic cancer - description of a rare patient group
por: Habermehl, Daniel, et al.
Publicado: (2014)

First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas
por: Dittmar, Jan Oliver, et al.
Publicado: (2017)

Single-dose radiosurgical treatment for hepatic metastases - therapeutic outcome of 138 treated lesions from a single institution
por: Habermehl, Daniel, et al.
Publicado: (2013)

Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
por: Habermehl, Daniel, et al.
Publicado: (2015)

Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning
por: El Shafie, Rami A., et al.
Publicado: (2018)

Neurological outcome after emergency radiotherapy in MSCC of patients with non-small cell lung cancer - a prospective trial
por: Rief, Harald, et al.
Publicado: (2013)

In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines
por: El Shafie, Rami A., et al.
Publicado: (2013)

First experiences in treatment of low-grade glioma grade I and II with proton therapy
por: Hauswald, Henrik, et al.
Publicado: (2012)

Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy
por: Haefner, Matthias F., et al.
Publicado: (2015)

Prior surgical intervention and tumor size impact clinical outcome after precision radiotherapy for the treatment of optic nerve sheath meningiomas (ONSM)
por: Adeberg, Sebastian, et al.
Publicado: (2011)

The influence of orthopedic corsets on the incidence of pathological fractures in patients with spinal bone metastases after radiotherapy
por: Rief, Harald, et al.
Publicado: (2015)

Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial
por: Combs, Stephanie E, et al.
Publicado: (2011)

Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
por: El Shafie, Rami A., et al.
Publicado: (2020)

A treatment planning study of combined carbon ion-beam plus photon intensity-modulated radiotherapy
por: Schuppert, Christopher, et al.
Publicado: (2020)

Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) – the ESMERALDA trial
por: Habermehl, Daniel, et al.
Publicado: (2015)

Stereotactic radiotherapy of brain metastases: clinical impact of three-dimensional SPACE imaging for 3T-MRI-based treatment planning
por: Welzel, Thomas, et al.
Publicado: (2022)

Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity
por: Haefner, Matthias Felix, et al.
Publicado: (2017)

The stability of osseous metastases of the spine in lung cancer – a retrospective analysis of 338 cases
por: Rief, Harald, et al.
Publicado: (2013)

Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma
por: Akbaba, Sati, et al.
Publicado: (2018)

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series
por: Bernhardt, Denise, et al.
Publicado: (2018)

Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial
por: Combs, Stephanie E, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5ti78sqqfa4shvh68mo6rp1hoe